Company Snapshot
Assort Health is a Biotech company, based in San Francisco, California, USA, founded 2023 by Jon Wang, Jeffery Liu.
Recent changes
- Jun 24, 2026Jun 24, 2026Raised $120M Series C at a $1.2B valuation Menlo Ventures
- Jun 24, 2026Jun 24, 2026New investor: Menlo Ventures Menlo Ventures
- Jun 24, 2026Jun 24, 2026Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI Agents Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2026 | Series C | $120M | $1.2B | Menlo VenturesLead | Menlo Ventures |
Investors
Latest Pulse
- Jul 5, 2026Vertical AI Series A Rounds Are Quietly Getting BiggerA cluster of recent Series A and C rounds -- General Intuition's $320M, RunPod's $100M and Assort Health's $120M among them -- shows vertical AI applications commanding round sizes once reserved for infrastructure megadeals.→
- Jun 24, 2026Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI AgentsAssort Health raised a $120 million Series C led by Menlo Ventures at a $1.2 billion post-money valuation, vaulting the patient-access automation startup into unicorn territory. Its AI agents handle scheduling, intake, referrals, document processing and front-desk support for healthcare providers -- one of the clearest examples of AI moving from chatbot demos to embedded, revenue-bearing clinical workflows.→
- Jun 24, 2026Taktile Raises $110M Series C Led by Goldman Sachs for AI Decisioning in FinanceTaktile raised a $110 million Series C led by Goldman Sachs Alternatives to scale its AI decisioning platform, which lets banks and insurers automate underwriting, claims, fraud detection and anti-money-laundering workflows with human oversight. The round is a vote of confidence that regulated financial institutions will pay for AI that makes high-stakes decisions auditable rather than just faster.→
Coverage Timeline
newest firstAll Coverage
FUNDING$650M+ combined across 4 vertical rounds
Vertical AI Series A Rounds Are Quietly Getting Bigger
A cluster of recent Series A and C rounds -- General Intuition's $320M, RunPod's $100M and Assort Health's $120M among them -- shows vertical AI applications commanding round sizes once reserved for infrastructure megadeals.
Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI Agents
FUNDING$120M
Assort Health Raises $120M Series C at a $1.2B Valuation for Healthcare AI Agents
Assort Health raised a $120 million Series C led by Menlo Ventures at a $1.2 billion post-money valuation, vaulting the patient-access automation startup into unicorn territory. Its AI agents handle scheduling, intake, referrals, document processing and front-desk support for healthcare providers -- one of the clearest examples of AI moving from chatbot demos to embedded, revenue-bearing clinical workflows.
Related Companies
Assort Health FAQ
Who are Assort Health's investors?
Assort Health's investors include Menlo Ventures, Capital A Partners, Chemistry VC, Chemistry Ventures, Felicis Ventures, and 5 more (As of 2026-07-30T20:03:01Z).
Sources & methodologyshow
Where these figures come from
- Menlo VenturesValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.